Suppr超能文献

大多数基底样乳腺癌表现出与HPV相关的低分化鳞状细胞癌相同的Rb-/p16+免疫表型,它们在形态学上与之相似。

Most basal-like breast carcinomas demonstrate the same Rb-/p16+ immunophenotype as the HPV-related poorly differentiated squamous cell carcinomas which they resemble morphologically.

作者信息

Subhawong Andrea Proctor, Subhawong Ty, Nassar Hind, Kouprina Nina, Begum Shahnaz, Vang Russell, Westra William H, Argani Pedram

机构信息

Department of Pathology, The Johns Hopkins Medical Institutions, MD 21231-2410, USA.

出版信息

Am J Surg Pathol. 2009 Feb;33(2):163-75. doi: 10.1097/PAS.0b013e31817f9790.

Abstract

Basal-like carcinomas (BLCs) of the breast share discriminatory morphologic features with poorly differentiated high-risk human papilloma virus (HPV)-related squamous cell carcinomas of the oropharynx, penis, and vulva. Because HPV E7 protein inactivates the retinoblastoma (Rb) protein, diffuse p16 expression is a surrogate marker for these high-risk HPV-related carcinomas. HPV E6 protein also inactivates p53, further compromising the G1-S cell cycle checkpoint. The Rb/p16/p53 immunohistochemical profile of BLC of the breast has not been well characterized. Tissue microarrays containing 71 invasive ductal carcinomas (IDCs) of the breast were immunolabeled for p16, Rb, p53, and Ki-67. The cases included 4 distinct groups of IDCs having surrogate immunohistochemical profiles corresponding to categories defined by gene expression profiling (17 luminal A, 7 luminal B, 14 HER-2+, and 21 BLC), along with 12 unclassifiable triple negative carcinomas (UTNCs). Twenty-five of the 71 IDC were Rb negative/p16 diffuse positive (Rb-/p16+). These included 15 of 21 BLC and 9 of 12 UTNC, but only 1 of 14 HER-2 positive cases and none of the 17 luminal A or 7 luminal B cases (P<0.01, BLC or UTNC vs. others). Six of the Rb-/p16+ IDC also had a significant ductal carcinoma in situ component. The ductal carcinoma in situ in 4 of these 6 cases showed the same Rb-/p16+ phenotype as the associated IDC. BLC and UTNC had the highest Ki-67 indices of the 5 groups, even when matched for grade. The Rb-/p16+ phenotype and the Rb-/p16+/p53 overexpressing phenotype correlated with increased proliferation within the BLC group. In conclusion, BLC and UTNC, but not HER-2, luminal A, or luminal B carcinomas, frequently demonstrate an Rb-/p16+ phenotype, similar to the HPV-related squamous cell carcinomas that BLC resemble morphologically. This subset may represent a more homogenous group than BLC as defined currently.

摘要

乳腺基底样癌(BLC)与口咽、阴茎和外阴的低分化高危人乳头瘤病毒(HPV)相关鳞状细胞癌具有相似的鉴别性形态学特征。由于HPV E7蛋白可使视网膜母细胞瘤(Rb)蛋白失活,弥漫性p16表达是这些高危HPV相关癌的替代标志物。HPV E6蛋白也可使p53失活,进一步破坏G1-S细胞周期检查点。乳腺BLC的Rb/p16/p53免疫组化特征尚未得到充分表征。对包含71例乳腺浸润性导管癌(IDC)的组织芯片进行p16、Rb、p53和Ki-67免疫标记。这些病例包括4组不同的IDC,其具有与基因表达谱定义的类别相对应的替代免疫组化特征(17例腔面A型、7例腔面B型、14例HER-2阳性型和21例BLC),以及12例无法分类的三阴性癌(UTNC)。71例IDC中有25例为Rb阴性/p16弥漫性阳性(Rb-/p16+)。其中包括21例BLC中的15例、12例UTNC中的9例,但14例HER-2阳性病例中只有1例,17例腔面A型或7例腔面B型病例中均无(P<0.01,BLC或UTNC与其他类型相比)。6例Rb-/p16+的IDC还伴有显著的导管原位癌成分。这6例中的4例导管原位癌表现出与相关IDC相同的Rb-/p16+表型。即使在分级匹配的情况下,BLC和UTNC在5组中Ki-67指数最高。Rb-/p16+表型和Rb-/p16+/p5三过度表达表型与BLC组内增殖增加相关。总之,BLC和UTNC,而非HER-2、腔面A型或腔面B型癌,经常表现出Rb-/p16+表型,类似于BLC在形态学上与之相似的HPV相关鳞状细胞癌。与目前定义的BLC相比,这一亚组可能代表一个更具同质性的群体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a4a/2965595/8947ea073e4a/nihms243756f1.jpg

相似文献

引用本文的文献

本文引用的文献

2
Triple negative tumours: a critical review.三阴性肿瘤:一项批判性综述。
Histopathology. 2008 Jan;52(1):108-18. doi: 10.1111/j.1365-2559.2007.02889.x.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验